https://stock.noler.com/us/stock/coeptis-therapeutics-inc https://stock.noler.com/us/stock/coeptis-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/coeptis-therapeutics-inc/accounts-receivable https://stock.noler.com/us/stock/coeptis-therapeutics-inc/accrued-liabilities-current https://stock.noler.com/us/stock/coeptis-therapeutics-inc/accrued-royalties-current-and-noncurrent https://stock.noler.com/us/stock/coeptis-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/coeptis-therapeutics-inc/additional-paid-in-capital https://stock.noler.com/us/stock/coeptis-therapeutics-inc/advance-royalties https://stock.noler.com/us/stock/coeptis-therapeutics-inc/amortization https://stock.noler.com/us/stock/coeptis-therapeutics-inc/assets-noncurrent https://stock.noler.com/us/stock/coeptis-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/coeptis-therapeutics-inc/buybacks-share-repurchases https://stock.noler.com/us/stock/coeptis-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/coeptis-therapeutics-inc/capital-units-authorized https://stock.noler.com/us/stock/coeptis-therapeutics-inc/cash https://stock.noler.com/us/stock/coeptis-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/coeptis-therapeutics-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/coeptis-therapeutics-inc/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/coeptis-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/coeptis-therapeutics-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/coeptis-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/coeptis-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/coeptis-therapeutics-inc/consideration-received-for-beneficial-interest-obtained-for-transferring-financial-asset https://stock.noler.com/us/stock/coeptis-therapeutics-inc/contract-liability https://stock.noler.com/us/stock/coeptis-therapeutics-inc/convertible-debt https://stock.noler.com/us/stock/coeptis-therapeutics-inc/cost-of-revenue https://stock.noler.com/us/stock/coeptis-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/coeptis-therapeutics-inc/current-assets https://stock.noler.com/us/stock/coeptis-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/coeptis-therapeutics-inc/debt-decrease-forgiveness https://stock.noler.com/us/stock/coeptis-therapeutics-inc/debt-maturing-after-year-five https://stock.noler.com/us/stock/coeptis-therapeutics-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/coeptis-therapeutics-inc/debt-maturing-in-year-five https://stock.noler.com/us/stock/coeptis-therapeutics-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/coeptis-therapeutics-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/coeptis-therapeutics-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/coeptis-therapeutics-inc/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/coeptis-therapeutics-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/coeptis-therapeutics-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/coeptis-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/coeptis-therapeutics-inc/defined-benefit-plan-contributions-by-employer https://stock.noler.com/us/stock/coeptis-therapeutics-inc/depreciation-and-amortization https://stock.noler.com/us/stock/coeptis-therapeutics-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/coeptis-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/coeptis-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/coeptis-therapeutics-inc/entertainment-license-agreement-for-program-material-not-in-film-group-impairment https://stock.noler.com/us/stock/coeptis-therapeutics-inc/eps https://stock.noler.com/us/stock/coeptis-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/coeptis-therapeutics-inc/extinguishment-of-debt-gain-loss-net-of-tax https://stock.noler.com/us/stock/coeptis-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/coeptis-therapeutics-inc/finite-lived-contractual-rights-gross https://stock.noler.com/us/stock/coeptis-therapeutics-inc/form-d-stocks https://stock.noler.com/us/stock/coeptis-therapeutics-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/coeptis-therapeutics-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/coeptis-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/coeptis-therapeutics-inc/gross-profit https://stock.noler.com/us/stock/coeptis-therapeutics-inc/income-tax https://stock.noler.com/us/stock/coeptis-therapeutics-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/coeptis-therapeutics-inc/income-taxes-paid https://stock.noler.com/us/stock/coeptis-therapeutics-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/coeptis-therapeutics-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/coeptis-therapeutics-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/coeptis-therapeutics-inc/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/coeptis-therapeutics-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/coeptis-therapeutics-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/coeptis-therapeutics-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/coeptis-therapeutics-inc/increase-decrease-in-other-current-assets https://stock.noler.com/us/stock/coeptis-therapeutics-inc/insider-transactions-preferred https://stock.noler.com/us/stock/coeptis-therapeutics-inc/interest-expense https://stock.noler.com/us/stock/coeptis-therapeutics-inc/interest-expense-related-party https://stock.noler.com/us/stock/coeptis-therapeutics-inc/interest-paid-net https://stock.noler.com/us/stock/coeptis-therapeutics-inc/interest-payable-current https://stock.noler.com/us/stock/coeptis-therapeutics-inc/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/coeptis-therapeutics-inc/inventory https://stock.noler.com/us/stock/coeptis-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/coeptis-therapeutics-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/coeptis-therapeutics-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/coeptis-therapeutics-inc/liabilities-noncurrent https://stock.noler.com/us/stock/coeptis-therapeutics-inc/loans-payable-current https://stock.noler.com/us/stock/coeptis-therapeutics-inc/long-term-debt https://stock.noler.com/us/stock/coeptis-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/coeptis-therapeutics-inc/net-income https://stock.noler.com/us/stock/coeptis-therapeutics-inc/notes-payable-current https://stock.noler.com/us/stock/coeptis-therapeutics-inc/notes-payable-related-parties-classified-current https://stock.noler.com/us/stock/coeptis-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/coeptis-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/coeptis-therapeutics-inc/operating-income https://stock.noler.com/us/stock/coeptis-therapeutics-inc/operating-lease-assets https://stock.noler.com/us/stock/coeptis-therapeutics-inc/operating-lease-expense https://stock.noler.com/us/stock/coeptis-therapeutics-inc/operating-lease-liability https://stock.noler.com/us/stock/coeptis-therapeutics-inc/operating-lease-liability-current https://stock.noler.com/us/stock/coeptis-therapeutics-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/coeptis-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/coeptis-therapeutics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/coeptis-therapeutics-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/coeptis-therapeutics-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/coeptis-therapeutics-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/coeptis-therapeutics-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/coeptis-therapeutics-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/coeptis-therapeutics-inc/other-assets https://stock.noler.com/us/stock/coeptis-therapeutics-inc/other-current-assets https://stock.noler.com/us/stock/coeptis-therapeutics-inc/other-income https://stock.noler.com/us/stock/coeptis-therapeutics-inc/other-income-2 https://stock.noler.com/us/stock/coeptis-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/coeptis-therapeutics-inc/other-receivables-net-current https://stock.noler.com/us/stock/coeptis-therapeutics-inc/paid-in-capital-other https://stock.noler.com/us/stock/coeptis-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/coeptis-therapeutics-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/coeptis-therapeutics-inc/paid-in-kind-interest https://stock.noler.com/us/stock/coeptis-therapeutics-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/coeptis-therapeutics-inc/payments-to-acquire-other-productive-assets https://stock.noler.com/us/stock/coeptis-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/coeptis-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/coeptis-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/coeptis-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/coeptis-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/coeptis-therapeutics-inc/preferred-stock-value https://stock.noler.com/us/stock/coeptis-therapeutics-inc/pretax-income https://stock.noler.com/us/stock/coeptis-therapeutics-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/coeptis-therapeutics-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/coeptis-therapeutics-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/coeptis-therapeutics-inc/proceeds-from-other-equity https://stock.noler.com/us/stock/coeptis-therapeutics-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/coeptis-therapeutics-inc/proceeds-from-repayments-of-notes-payable https://stock.noler.com/us/stock/coeptis-therapeutics-inc/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/coeptis-therapeutics-inc/proceeds-from-royalties-received https://stock.noler.com/us/stock/coeptis-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/coeptis-therapeutics-inc/professional-fees https://stock.noler.com/us/stock/coeptis-therapeutics-inc/profit-loss https://stock.noler.com/us/stock/coeptis-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/coeptis-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/coeptis-therapeutics-inc/public-float https://stock.noler.com/us/stock/coeptis-therapeutics-inc/related-party-transaction-selling-general-and-administrative-expenses-from-transactions-with-related-party https://stock.noler.com/us/stock/coeptis-therapeutics-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/coeptis-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/coeptis-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/coeptis-therapeutics-inc/revenue https://stock.noler.com/us/stock/coeptis-therapeutics-inc/royalty-expense https://stock.noler.com/us/stock/coeptis-therapeutics-inc/royalty-income-nonoperating https://stock.noler.com/us/stock/coeptis-therapeutics-inc/selling-and-marketing-expense https://stock.noler.com/us/stock/coeptis-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/coeptis-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/coeptis-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/coeptis-therapeutics-inc/shares-repurchased https://stock.noler.com/us/stock/coeptis-therapeutics-inc/stock-and-warrants-issued-value-preferred-stock-and-warrants https://stock.noler.com/us/stock/coeptis-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/coeptis-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/coeptis-therapeutics-inc/stock-issued-shares-issued-shares-other https://stock.noler.com/us/stock/coeptis-therapeutics-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/coeptis-therapeutics-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities-net-of-adjustments https://stock.noler.com/us/stock/coeptis-therapeutics-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/coeptis-therapeutics-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/coeptis-therapeutics-inc/stock-repurchased-shares https://stock.noler.com/us/stock/coeptis-therapeutics-inc/stockholders-equity-note-subscriptions-receivable https://stock.noler.com/us/stock/coeptis-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/coeptis-therapeutics-inc/taxes-and-licenses https://stock.noler.com/us/stock/coeptis-therapeutics-inc/total-assets https://stock.noler.com/us/stock/coeptis-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/coeptis-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/coeptis-therapeutics-inc/total-long-term-debt https://stock.noler.com/us/stock/coeptis-therapeutics-inc/treasury-stock-shares https://stock.noler.com/us/stock/coeptis-therapeutics-inc/treasury-stock-shares-retired https://stock.noler.com/us/stock/coeptis-therapeutics-inc/treasury-stock-value https://stock.noler.com/us/stock/coeptis-therapeutics-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/coeptis-therapeutics-inc/weighted-average-number-of-limited-partnership-and-general-partnership-unit-outstanding-basic-and-diluted https://stock.noler.com/us/stock/coeptis-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted